SCHEMBL4433741

SCHEMBL4433741

CC(=O)N1CC(O)C(O)C1C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.46
POLB P06746 1/20 0.32
GBA2 Q9HCG7 1/20 0.30
MMP2 P08253 1/20 0.30
ANPEP P15144 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4433742 1.00 ATM (0.46) ATMPOLBGBA2MMP2ANPEP
SCHEMBL5065952 0.83 ATM (0.31) ATMGBA2
SCHEMBL5065905 0.83 ATM (0.31) ATMGBA2
SCHEMBL19083905 0.82 ATM (0.44) ATMPOLB
SCHEMBL19084072 0.82 ATM (0.44) ATMPOLB
SCHEMBL19083919 0.82 ATM (0.44) ATMPOLB
SCHEMBL7211294 0.74 GAA (0.42) ATMGBA2
SCHEMBL7211297 0.74 GAA (0.42) ATMGBA2
SCHEMBL468848 0.72 ATM (0.42) ATMPOLB
SCHEMBL4251630 0.72 ATM (0.42) ATMPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2117536-A2 COSMETIC AND PHARMACEUTICAL APPLICATIONS OF N-ACYLATED AMINO ACIDS AND STRUCTURALLY RELATED COMPOUNDS Beiersdorf AG (DE) 2009-11-18 EP claimed
WO-2008101693-A2 COSMETIC AND PHARMACEUTICAL APPLICATIONS OF N-ACYLATED AMINO ACIDS AND STRUCTURALLY RELATED COMPOUNDS BEIERSDORF AG (DE) 2008-08-28 WO claimed
EP-2117536-A2 COSMETIC AND PHARMACEUTICAL APPLICATIONS OF N-ACYLATED AMINO ACIDS AND STRUCTURALLY RELATED COMPOUNDS Beiersdorf AG (DE) 2009-11-18 EP disclosed
WO-2008101693-A2 COSMETIC AND PHARMACEUTICAL APPLICATIONS OF N-ACYLATED AMINO ACIDS AND STRUCTURALLY RELATED COMPOUNDS BEIERSDORF AG (DE) 2008-08-28 WO disclosed
EP-1009420-B1 CONJUGATES USEFUL IN THE TREATMENT OF PROSTATE CANCER MERCK & CO INC (US) 2003-12-17 EP disclosed
EP-0942754-B1 CONJUGATES USEFUL IN THE TREATMENT OF PROSTATE CANCER MERCK & CO INC (US) 2003-05-07 EP disclosed
CN-1242708-A Conjugates for the treatment of prostate cancer MERCK & CO INC (US) 2000-01-26 CN disclosed
US-5948750-A OLIGOPEPTIDES, HAVING AMINO ACID SEQUENCES THAT ARE SELECTIVELY PROTEOLYTICALLY CLEAVED BY FREE PROSTATE SPECIFIC ANTIGEN (PSA) AND KNOWN CYTOTOXIC AGENTS ARE DISCLOSED. SUCH CONJUGATES ARE USEFUL IN THE TREATMENT OF PROSTATIC CANCER AND MERCK & CO., INC. (US) 1999-09-07 US disclosed